Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

The sum for semaglutide has been clocked up in just over a year, it has emerged – but the Ministry of Defence claims obesity ...

The body does not absorb berberine well, limiting its ability to affect body weight significantly. However, berberine may ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

LynFit Nutrition is a recurring segment featured on CT BUZZ, where Celebrity Nutrition & Fitness Expert, Lisa Lynn shares her insights and experience with Reporter ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Online pharmacies are now required to implement stricter verification checks before prescribing weight-loss drugs (also known as GLP1 medications) such as Wegovy and Mounjaro to patients.

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...